Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Fintel reports that on February 13, 2025, Evercore ISI Group downgraded their outlook for Trade Desk (NasdaqGM:TTD) from ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Entropy Technologies LP purchased a new stake in Artisan Partners Asset Management Inc. (NYSE:APAM – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & ...

Riot also announced it has hired investment banks Evercore and Northland Capital Markets to lead discussions with potential ...

In a report released today, Ryan Kenny from Morgan Stanley maintained a Buy rating on Evercore Partners (EVR – Research Report), with a price ...

KBW analyst Aidan Hall reiterated a Buy rating on Evercore Partners (EVR – Research Report) today and set a price target of $339.00. The ...

Evercore Partners Inc (NYSE:EVR) reported its fourth-quarter 2024 earnings, surpassing analyst expectations with an EPS of $3.41 against a forecast of $3.04. The company also exceeded revenue ...

Sources said Atrium and owner Stone Point have engaged Evercore to advise on the work ... with its co-investor Enstar in 2020, after the partners had evaluated market interest in a sale in ...